Colorado Cancer Blogs
  • Home
  • Topics
    • Latest News
    • Research
    • Patient Care
    • Philanthropy
    • C3 Magazine
    • Honors
  • Cancer Types
    • bladder cancer
    • blood cancer
    • brain cancer
    • breast cancer
    • colorectal cancer
    • gynecologic cancer
    • head & neck cancer
    • lung cancer
    • pancreatic cancer
    • pediatric cancer
    • prostate cancer
    • sarcoma
    • skin cancer
Select Page
D. Ross Camidge, MD, PhD: COVID-19 lung cancer treatment diary

D. Ross Camidge, MD, PhD: COVID-19 lung cancer treatment diary

by Ross Camidge | May 14, 2020 | Featured, Patient Care

D. Ross Camidge, MD, PhD, director of thoracic oncology and the Joyce Zeff Chair in Lung Cancer Research at the University of Colorado Cancer Center March 5th: The first confirmed case of COVID-19 in Colorado is reported in a young man who had been on vacation to...
Variation in how side effects are reported leaves first impressions of new anti-cancer drugs open to manipulation

Variation in how side effects are reported leaves first impressions of new anti-cancer drugs open to manipulation

by Garth Sundem | Apr 28, 2020 | Featured, Latest News, Research

Emily Simons, MD, MPH An important goal of early-phase clinical trials is to discover a drug’s possible side effects. But despite FDA guidelines seeking to standardize this reporting, a University of Colorado Cancer Center study finds significant variation in how drug...
With smaller clinical trials, it may be up to doctors to notice rare drug side effects

With smaller clinical trials, it may be up to doctors to notice rare drug side effects

by Garth Sundem | Apr 22, 2020 | Featured, Latest News, Research

Tejas Patil, MD Tejas Patil, MD, is a medical oncologist. Lisa Ferrigno, MD, MPH, FACS, is a trauma surgeon. Working with lung cancer patients at University of Colorado Cancer Center, they both, independently, noticed something strange: A small percentage of patients...
African Americans, Hispanics less likely to receive recommended lung cancer imaging

African Americans, Hispanics less likely to receive recommended lung cancer imaging

by Garth Sundem | Mar 11, 2020 | Featured, Latest News

Rustain Morgan, MD, CU Cancer Center investigator and assistant professor in the CU School of Medicine Department of Radiology The use of PET-CT imaging gives doctors the best possible picture of non-small cell lung cancer (NSCLC), and this accurate imaging helps to...
Lancet Oncology: Entrectinib effective, well-tolerated against ROS1 and NTRK lung cancers, especially with brain metastases

Lancet Oncology: Entrectinib effective, well-tolerated against ROS1 and NTRK lung cancers, especially with brain metastases

by Garth Sundem | Dec 13, 2019 | Featured, Latest News

Robert C. Doebele, MD, PhD Pooled analysis of three phase 1 and 2 clinical trials published online ahead of print in the journal Lancet Oncology show that the drug entrectinib is effective and well-tolerated against advanced ROS1 and NTRK fusion-positive non-small...
« Older Entries

Colorado Cancer Blogs

  • About Us
  • Comment Policy
  • Cover My News!

CU Cancer Center

  • Find a Doctor
  • Clinical Trials
  • Remote Second Opinion
  • Events

Subscribe to CU Cancer Blogs via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

  • Facebook
  • Twitter
  • Instagram

Copyright © 2021 Colorado Cancer Blogs